Active · per the CBE, 17 November 2026

LELIMA PHARMA

BE0691649590

Rechtspersoon Private limited company 1 establishment

LELIMA PHARMA is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 1 March 2018, 1 establishment.

Rue Croix Thomas 6, 1341 Ottignies-Louvain-la-Neuve

Behind the company: CEDRIC MEEUW.

Active for

8 year, 8 months

Financials

Financial year 2026

LELIMA PHARMA from Ottignies-Louvain-la-Neuve, company number BE0691649590, closed financial year 2026 with a result of € 54,519 after tax. For that financial year LELIMA PHARMA recorded a gross margin of € 70,644 and equity of € 247,899. Compared with financial year 2025, the result moved from € 45,404 to € 54,519. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 21, 2026.

What it is worth Growing

€ 247,899

▲ 28% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 54,519

▲ 20% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 142,665

▲ 45% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2026. Retained profit grew to € 229,299.

People and assets in 2026

Vehicles and equipment

€ 1,334

▼ 67% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt ≈ 13 years to go

€ 934,673

▲ € 932,036 vs 2025

€ 73,933 is repaid this year. At this pace the long-term loan is gone in ≈ 13 years.

Owed to suppliers

€ 108,186

▲ € 105,536 vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,294

▼ 60% vs 2025

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
2023202420252026Change 2025 → 2026
Gross margin € 64,050 € 63,405 € 58,622 € 70,644 ▲ 21%
Profit after taxes € 44,006 € 45,392 € 45,404 € 54,519 ▲ 20%
Equity € 102,584 € 147,976 € 193,380 € 247,899 ▲ 28%
Total debts € 17,075 € 25,189 € 13,459 € 1,046,154 ▲ € 1 million
Cash € 73,405 € 92,379 € 98,277 € 142,665 ▲ 45%
Retained profit € 83,984 € 129,376 € 174,780 € 229,299 ▲ 31%
Bank debt € 60 € 6,814 € 2,638 € 934,673 ▲ € 932,036
Balance sheet total € 119,659 € 173,165 € 206,839 € 1,294,053 ▲ € 1.1 million

By gross margin, LELIMA PHARMA ranks 20th of 41 companies with main activity “Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies” in Ottignies-Louvain-la-Neuve that publish figures (fiscal year 2026).

Key figures of LELIMA PHARMA, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to LELIMA PHARMA?

What happened at LELIMA PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2026: profit of € 54,519 (▲ 20% vs 2025). Source: NBB ↗
  • CEDRIC MEEUW became a director. NBB
  • Incorporation, published in the Gazette. Source: Staatsblad ↗
  • New establishment in Ottignies-Louvain-la-Neuve. KBO

In short

From € 44,006 profit in 2023 to € 54,519 profit in 2026.

Paid € 51,353 in corporate taxes since 2023.

Best year ever: 2026, with € 54,519 profit.

Management

CEDRIC MEEUW
LELIMA PHARMA

Behind LELIMA PHARMA is CEDRIC MEEUW. It owns 100% of PHARDUP SA itself.

Directors

According to the 2026 annual accounts

CEDRIC MEEUW

Director

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Croix Thomas 6

1341 Ottignies-Louvain-la-Neuve

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Ottignies-Louvain-la-Neuve

Same main activity (Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies), 44 active companies in Ottignies-Louvain-la-Neuve, largest first.

PATRICE DELACROIX

€ 706,167 gross margin · 2025

ENERGIDEA

€ 494,250 gross margin · 2025

HG Pharma

€ 367,522 gross margin · 2025

PUBLIC AFFAIRS CLINIC

€ 264,583 gross margin · 2025

Conciergerie KGF

€ 223,496 gross margin · 2025

Badger & Hawthorn

€ 216,646 gross margin · 2025

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

Source: Deed ↗
  • Cédric MEEUW(oprichter) 99.5%
  • Julie HAINE(oprichter) 0.5%

Details

Company number
0691.649.590
VAT number
BE 0691.649.590
Registered office
Rue Croix Thomas 6, 1341 Ottignies-Louvain-la-Neuve
Names & denominations
LELIMA PHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
1 March 2018
Peppol
Active · Active since 26 Nov 2025
Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Frequently asked questions

What does LELIMA PHARMA do?
LELIMA PHARMA is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 1 March 2018, 1 establishment.
What is the address of LELIMA PHARMA?
The registered office of LELIMA PHARMA is located at Rue Croix Thomas 6, 1341 Ottignies-Louvain-la-Neuve.
Is LELIMA PHARMA still active?
Yes. According to the CBE (17 November 2026) LELIMA PHARMA is active, legal situation “Normale toestand”, started on 1 March 2018.
Is LELIMA PHARMA registered on Peppol?
Yes, LELIMA PHARMA is registered on the Peppol network with ID 0208:0691649590.
What is the enterprise number of LELIMA PHARMA?
The enterprise number of LELIMA PHARMA is BE0691649590.
When was LELIMA PHARMA founded?
LELIMA PHARMA was founded on 1 March 2018.